| Cat. No. |
Product Name |
Information |
| PC-36134 |
AZD5718
FLAP inhibitor
|
Atuliflapon (AZD-5718, AZD5718) is a novel potent 5-lipoxygenase activating protein (FLAP) inhibitor with binding IC50 of 6.3 nM. |
| PC-35038 |
BI 665915
FLAP inhibitor
|
BI 665915 is a highly potent, selective, orally active 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 1.7 nM. |
| PC-35037 |
ABT-080
FLAP inhibitor
|
ABT-080 is a potent FLAP inhibitor that inhibits ionophore-stimulated LTB(4) formation with with IC50 of 20 nM. |
| PC-42116 |
MK-0591
FLAP inhibitor
|
Quiflapon (MK-0591) is a potent, specific and orally active 5-Lipoxygenase-activating protein (FLAP) inhibitor with IC50 of 1.6 nM in FLAP binding assay. |
| PC-44769 |
GSK2190915 sodium
FLAP inhibitor
|
Fiboflapon (AM-803, GSK 2190915) sodium is a potent, selective 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 2.6 nM. |
| PC-44768 |
GSK2190915
FLAP inhibitor
|
Fiboflapon (AM-803, GSK 2190915) is a potent, selective 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 2.6 nM. |
| PC-45853 |
MK-591
FLAP inhibitor
|
Quiflapon (MK-591, MK-0591, L-686708) sodium is a potent, orally active leukotriene biosynthesis inhibitor that acts by inhibiting 5-lipoxygenase activating protein (FLAP) with IC50 of 1.6 nM in a FLAP binding assay. |
| PC-20006 |
MK-886
FLAP inhibitor
|
MK-886 (L-663,536) is a potent, selective and orally active inhibitor of 5-lipoxygenase-activating protein (FLAP) with IC50 of 30 nM. |
